NFKB1 and hepatocellular carcinoma: Therefore, the reduced activation and expression of Nrf2, along with the reduced activation of NF-κB and COX-2 as a result of treatment with OAO–IND conjugates in HCC cells, may inhibit their growth and invasiveness.